gynecology-congress-2018-scientifictracks

11 / 19

Page 28
Notes:
conferenceseries.com
Volume 8 Gynecology & Obstetrics Gynecology Congress 2018
August 22-23, 2018
August 22-23, 2018 Tokyo, Japan
5 th Asia Pacific
Gynecology and Obstetrics Congress
Hongwen Zhang, Gynecol Obstet 2018, Volume 8
DOI: 10.4172/2161-0932-C3-030
Clinical classification and treatment of cesarean scar pregnancy
Hongwen Zhang
The Second Xiangya Hospital of Central South University, China
Introduction &Aim: Embryo implantation in a cesarean scar resulting in a Cesarean Scar Pregnancy (CSP) is a special form of
ectopic pregnancy. The aim of this article is to present our clinical classification and therapeutic strategy for CSP and to assess
the efficacy, safety and social benefits.
Methods: We categorized CSP as either risky or stable. Risky CSP have a high risk of severe hemorrhage and should be
treated immediately, while stable CSP patients have neither obvious vaginal bleeding nor significantly elevated serum β -human
chorionic gonadotropin (β-hCG). According to the thickness of the myometrial wall between the sac and the bladder and the
location of the gestational sac, risky CSP were classified into three types and the thinner myometrial wall type (type-1) was
divided into three subtypes. Four treatment categories were applied to the corresponding types and subtypes of CSP. A total
of 331 patients with CSP in our hospital were studied. The study group (n=81) was treated based on our classification and
optimized treatment system, while the control group (n=250) underwent the conventional methods. We assessed the efficacy,
safety and social benefits of our classification and optimized treatment system.
Results: The values of intraoperative blood loss, operative time, hospital stay and hospital cost in the study group were
significantly lower than those in the control group (P<0.05). Suction curettage was more frequently used in the study group
(P<0.005).
Conclusion: Our clinical classification system and therapeutic strategy provide an effective and safe way to treat CSP patients
resulting in reduced intraoperative bleeding, operative time, hospital days and hospital cost.
Biography
Hongwen Zhang is a Professor in The Second Xiangya Hospital of Central South University and Chief of the Gynecology and Obstetrics Department. He has
nearly 40 years of clinical experience. He is skilled in gynecologic inflammation, female diseases, gynecological oncology, ureteroscope and laparoscope surgery.